Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Cyclin-dependent kinase 1 inhibitor RO3306 promotes mitotic slippage in paclitaxel-treated HepG2 cells.

Xiao J, Qiu P, Lai X, He P, Wu Y, Du B, Tan Y.

Neoplasma. 2013 Sep 20. doi: 10.4149/neo_2014_007. [Epub ahead of print]

PMID:
24050548
2.

Cyclin-dependent kinase 1 inhibitor RO3306 promotes mitotic slippage in paclitaxel-treated HepG2 cells.

Xiao J, Qiu P, Lai X, He P, Wu Y, Du B, Tan Y.

Neoplasma. 2014;61(1):41-7.

PMID:
24195507
3.

Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells.

Qu Z, Zou X, Zhang X, Sheng J, Wang Y, Wang J, Wang C, Ji Y.

Mol Med Rep. 2016 Feb;13(2):1336-44. doi: 10.3892/mmr.2015.4683. Epub 2015 Dec 14.

PMID:
26677104
5.

Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy.

Giovinazzi S, Bellapu D, Morozov VM, Ishov AM.

Cell Cycle. 2013 Aug 15;12(16):2598-607. doi: 10.4161/cc.25591. Epub 2013 Jul 9.

7.

Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.

You N, Liu W, Wang T, Ji R, Wang X, Gong Z, Dou K, Tao K.

Oncol Rep. 2012 Dec;28(6):2091-100. doi: 10.3892/or.2012.2035. Epub 2012 Sep 17.

PMID:
22993037
8.

Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1.

Wang T, Lv JH, Zhang XF, Li CJ, Han X, Sun YJ.

Int J Cancer. 2010 Jan 15;126(2):362-70. doi: 10.1002/ijc.24753.

9.

Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.

Cai X, Hu X, Cai B, Wang Q, Li Y, Tan X, Hu H, Chen X, Huang J, Cheng J, Jing X.

Oncol Rep. 2013 Nov;30(5):2449-57. doi: 10.3892/or.2013.2718. Epub 2013 Sep 4.

PMID:
24008375
10.

Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis.

Demidenko ZN, Kalurupalle S, Hanko C, Lim CU, Broude E, Blagosklonny MV.

Oncogene. 2008 Jul 24;27(32):4402-10. doi: 10.1038/onc.2008.82. Epub 2008 May 12.

PMID:
18469851
12.
13.

The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel.

Sakashita F, Osada S, Takemura M, Imai H, Tomita H, Nonaka K, Takahashi T, Seishima M.

Cancer Chemother Pharmacol. 2008 Aug;62(3):379-85. Epub 2007 Oct 25.

PMID:
17960385
14.

Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes.

Duan XF, Wu YL, Xu HZ, Zhao M, Zhuang HY, Wang XD, Yan H, Chen GQ.

Chem Biol Interact. 2010 Jan 5;183(1):222-30. doi: 10.1016/j.cbi.2009.09.012. Epub .

PMID:
19781537
15.

2'-epi-2'-O-Acetylthevetin B extracted from seeds of Cerbera manghas L. induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.

Feng B, Guo YW, Huang CG, Li L, Chen RH, Jiao BH.

Chem Biol Interact. 2010 Jan 5;183(1):142-53. doi: 10.1016/j.cbi.2009.10.012. Epub .

PMID:
19874809
16.

Paclitaxel induces primary and postmitotic G1 arrest in human arterial smooth muscle cells.

Blagosklonny MV, Darzynkiewicz Z, Halicka HD, Pozarowski P, Demidenko ZN, Barry JJ, Kamath KR, Herrmann RA.

Cell Cycle. 2004 Aug;3(8):1050-6. Epub 2004 Aug 24.

PMID:
15254417
18.

Silibinin efficacy against human hepatocellular carcinoma.

Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R.

Clin Cancer Res. 2005 Dec 1;11(23):8441-8.

19.

A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.

Dai XY, Zeng XX, Peng F, Han YY, Lin HJ, Xu YZ, Zhou T, Xie G, Deng Y, Mao YQ, Yu LT, Yang L, Zhao YL.

Cell Physiol Biochem. 2012;29(1-2):281-90. doi: 10.1159/000337609. Epub 2012 Mar 1.

PMID:
22415097
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk